Internal Medicine, Nephrology · Baltimore, MD
NPI
1053365486
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
4940 Eastern Ave
Baltimore, MD, 21224
Phone (410) 550-1800
Groups this clinician bills Medicare through
Medicare paid, 2024
$126K
1,000 services
Medicare patients, 2024
299
Average age 71
Drug cost, 2024
$416K
453 prescriptions
Company payments, 2025
$39K
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Duvuru Geetha was code 99233 (hospital e&m - subsequent), 179 times for 95 patients. In total Duvuru Geetha billed 1,000 services in 21 codes, and Medicare paid $126K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-02-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 179 | 95 | $95.55 | $17K |
| 90960 ESRD Related Services (not dialysis) | Office | 178 | 21 | $286.33 | $51K |
| 90935 Hemodialysis | Facility | 101 | 50 | $57.18 | $5,775 |
| 99215 Office E&M - Established | Office | 93 | 57 | $137.48 | $13K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 82 | 55 | $13.14 | $1,078 |
| 99222 Hospital E&M - Initial | Facility | 75 | 74 | $103.80 | $7,785 |
| 99232 Hospital E&M - Subsequent | Facility | 52 | 36 | $63.77 | $3,316 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 46 | 38 | $12.82 | $590 |
| 90945 Peritoneal Dialysis | Facility | 37 | 12 | $65.56 | $2,426 |
| 99214 Office E&M - Established | Facility | 34 | 32 | $76.87 | $2,614 |
| 99215 Office E&M - Established | Facility | 26 | 19 | $100.75 | $2,620 |
| 90961 ESRD Related Services (not dialysis) | Office | 20 | 13 | $238.23 | $4,765 |
By year: 2022 $144K for 985 services; 2023 $126K for 809 services; 2024 $126K for 1,000 services.
Medicare prescription drug claims, 2024
In 2024, the drug Duvuru Geetha prescribed most often to Medicare patients was Prednisone, with 29 prescriptions and refills. In total Duvuru Geetha wrote 453 Medicare prescriptions that cost $416K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 29 | 67 | Under 11 | $232 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 27 | 77 | Under 11 | $175 |
| Lisinopril Generic | 27 | 54 | Under 11 | $476 |
| Sevelamer Carbonate Generic | 24 | 38 | Under 11 | $7,589 |
| Calcitriol Generic | 24 | 48 | Under 11 | $601 |
| Mycophenolate Mofetil Generic | 21 | 61 | Under 11 | $2,493 |
| Furosemide Generic | 21 | 45 | Under 11 | $61.96 |
| Tavneos Avacopan | 20 | 20 | Under 11 | $332K |
| Calcium Acetate Generic | 19 | 33 | Under 11 | $1,404 |
| Gentamicin Sulfate Generic | 17 | 17 | Under 11 | $1,047 |
| Nifedipine Er Nifedipine | 17 | 41 | Under 11 | $865 |
| Famotidine Generic | 16 | 48 | Under 11 | $147 |
| Tacrolimus Generic | 15 | 35 | Under 11 | $2,930 |
| Lokelma Sodium Zirconium Cyclosilicate | 14 | 26 | Under 11 | $17K |
| Pantoprazole Sodium Generic | 13 | 23 | Under 11 | $154 |
Brand drugs: 65 claims; generic drugs: 388 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Duvuru Geetha $39K ($39K in general payments such as food, travel and fees and $17.33 for research) from 5 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $18K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.